Metastatic bone disease and the role of biochemical markers of bone metabolism in benign and malignant diseases
- 1 June 2001
- journal article
- editorial
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 27 (3) , 133-135
- https://doi.org/10.1053/ctrv.2000.0206
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Identifying Breast Cancer Patients at High Risk for Bone MetastasesJournal of Clinical Oncology, 2000
- Use of bisphosphonates for the treatment of bone metastasis in experimental animal modelsCancer Treatment Reviews, 1999
- Reduction in New Metastases in Breast Cancer with Adjuvant Clodronate TreatmentNew England Journal of Medicine, 1998
- Response of Biochemical Markers of Bone Turnover to Hormone Replacement Therapy: Impact of Biological VariabilityJournal of Bone and Mineral Research, 1998
- Measurement of serum osteocalcin with a human-specific two-site immunoradiometric assayJournal of Bone and Mineral Research, 1992